Ulcerative colitis patients with clostridium difficile are at increased risk of death, colectomy, and postoperative complications: A population-based inception cohort study

American Journal of Gastroenterology

Volumn 111, Issue 5, 2016, Pages 691-704

  Negrón, María E ^a,b   Rezaie, Ali ^c   Barkema, Herman W ^b   Rioux, Kevin ^a   De Buck, Jeroen ^b   Checkley, Sylvia ^b   Beck, Paul L ^a   Carroll, Matthew ^d   Fedorak, Richard N ^d   Dieleman, Levinus ^d   Panaccione, Remo ^a   Ghosh, Subrata ^a   Kaplan, Gilaad G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CLOSTRIDIUM INFECTION; COLON RESECTION; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; HUMAN; INFECTION RISK; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE INFECTION; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURGICAL RISK; SURVIVAL; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTIONS; COHORT ANALYSIS; COLITIS, ULCERATIVE; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; STATISTICAL MODEL;

ADULT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84964378550     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.106     Document Type: Article

References (35)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the Inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2011; 142: 46-54.e42
2. Kaplan GG. IBD: Global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol 2014; 11: 708-9
3. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015; 12: 720-7
4. Danese S, Fiorino G, Peyrin-Biroulet L, et al. Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. Ann Intern Med 2014; 160: 704-11
5. Frolkis AD, Dykeman J, Negron ME, et al. Risk of surgery for Inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013; 145: 996-1006
6. Kaplan GG, Seow CH, Ghosh S, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 2012; 107: 1879-87
7. Frolkis AD, Kaplan GG, Patel A, et al. Short-term emergent readmission and postoperative complications in children and adults with Inflammatory bowel disease who undergo intestinal resection-A population-based study. Inflamm Bowel Dis 2014; 20: 1316-23
8. de Silva S, Ma C, Proulx MC, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2011; 9: 972-80
9. Singh S, Al-Darmaki A, Frolkis AD, et al. Postoperative mortality among patients with Inflammatory bowel diseases: a systematic review and metaanalysis of population-based studies. Gastroenterology 2015; 149: 928-37
10. Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the Inflammatory bowel disease patient. Inflamm Bowel Dis 2013; 19: 194-204
11. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized Inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-50
12. Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with Inflammatory bowel disease. Dig Dis Sci 2014; 59: 2222-7
13. Murthy SK, Steinhart AH, Tinmouth J, et al. Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis. Aliment Pharmacol Ther 2012; 36: 1032-9
14. Ananthakrishnan AN, McGinley EL, Saeian K, et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with Inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 976-83
15. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on Inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 345-51
16. Navaneethan U, Mukewar S, Venkatesh PG, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis 2012; 6: 330-6
17. Jen MH, Saxena S, Bottle A, et al. Increased health burden associated with Clostridium difficile diarrhoea in patients with Inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 1322-1
18. Goodhand JR, Alazawi W, Rampton DS. Systematic review: Clostridium diffi -cile and Inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 428-41
19. Negron ME, Barkema HW, Rioux K, et al. Clostridium difficile infection worsens the prognosis of ulcerative colitis. Can J Gastroenterol Hepatol 2014; 28: 373-80
20. Molodecky NA, Pannacione R, Ghosh S, et al. Challenges associated with identifying the environmental determinants of the Inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17: 1792-9
21. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with Inflammatory bowel disease. Gut 2008; 57: 205-10
22. Ricciardi R, Ogilvie JW Jr., Roberts PL, et al. Epidemiology of Clostridium difficile colitis in hospitalized patients with Inflammatory bowel diseases. Dis Colon Rectum 2009; 52: 40-5
23. Health A. Alberta health care insurance plan 2014, http://www.health. alberta.ca/health-care-insurance-plan.html Accessed May 29, 2014, 2014
24. Rezaie A, Quan H, Fedorak R, et al. Development and validation of an administrative case defi nition for Inflammatory bowel diseases. Can J Gastroenterol 2012; 26: 711-8
25. Ma C, Crespin M, Proulx MC, et al. Postoperative complications following colectomy for ulcerative colitis: a validation study. BMC Gastroenterol 2012; 12: 39
26. Khan NA, Quan H, Bugar JM, et al. Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med 2006; 21: 177-80
27. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008; 134: 680-7
28. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defi ning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-9
29. Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geografi c dissemination of the Clostridium difficile North American Pulsed-Field Type 1 Strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007; 44: 238-44
30. Sundram F, Guyot A, Carboo I, et al. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. J Hosp Infect 2009; 72: 111-8
31. Yanai H, Nguyen GC, Yun L, et al. Practice of gastroenterologists in treating fl aring Inflammatory bowel disease patients with clostridium difficile: Antibiotics alone or combined antibiotics/immunomodulators? Inflamm Bowel Dis 2011; 17: 1540-6
32. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010; 55: 415-20
33. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 12: 790-801
34. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against Toxin A. N Engl J Med 2000; 342: 390-7
35. Ananthakrishnan AN, Oxford EC, Nguyen DD, et al. Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol Ther 2013; 38: 522-30